MicroRNA‑192 acts as a tumor suppressor in colon cancer and simvastatin activates miR‑192 to inhibit cancer cell growth

Zheng,Xiao‑Fang; Liu,Kun‑Xiang; Wang,Xin‑Mei; Zhang,Rui; Li,Xin

doi:10.3892/mmr.2019.9808

MicroRNA‑192 acts as a tumor suppressor in colon cancer and simvastatin activates miR‑192 to inhibit cancer cell growth

Authors:
- Xiao‑Fang Zheng
- Kun‑Xiang Liu
- Xin‑Mei Wang
- Rui Zhang
- Xin Li
View Affiliations

Affiliations: Department of Human Anatomy and Tissue Embryology, Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China, Department of Cell Biology, Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China
Published online on: January 2, 2019 https://doi.org/10.3892/mmr.2019.9808
Pages: 1753-1760

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon cancer is one of the most common malignant tumors worldwide. Understanding the underlying molecular mechanisms is crucial for the development of therapeutic strategies for the treatment of patients with colon cancer. In the present study, a novel tumor suppressive microRNA, miR‑192, was demonstrated to be markedly downregulated in colon cancer cells compared with normal colon cells. By overexpressing miR‑192 in colon cancer HCT‑116 cells, the results of the present study revealed that miR‑192 inhibits cell proliferation, migration and invasion. Bioinformatics were used to determine the target gene of miR‑192 and Ras‑related protein Rab‑2A (RAB2A) was identified as a downstream target of miR‑192. Following the determination of the role of the miR‑192‑RAB2A pathway in colon cancer, small molecules that may regulate miR‑192 were screened and the results demonstrated that simvastatin is an activator of miR‑192. Furthermore, simvastatin upregulated miR‑192 and inhibited the expression of downstream targets of miR‑192, which subsequently led to suppressed proliferation, migration and invasion of colon cancer cells. In conclusion, the present study identified a novel colon cancer cell suppressor, as well as a small‑molecule activator of the tumor suppressor miR‑192, which may represent a therapeutic strategy for the treatment of patients with colon cancer.

View Figures

View References

1	Van CE, Sagaert X, Topal B, Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664. 2016. View Article : Google Scholar : PubMed/NCBI
2	Elias D, Faron M, Iuga BS, Honoré C, Dumont F, Bourgain JL, Dartigues P, Ducreux M and Goéré D: Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers. Ann Surg. 261:157–163. 2015. View Article : Google Scholar : PubMed/NCBI
3	Lin H and Hannon GJ: Micro RNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
4	Uchino K, Takeshita F, Takahashi RU, Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa S, et al: Therapeutic effects of MicroRNA-582-5p and −3p on the inhibition of bladder cancer progression. Mol Ther. 21:610–619. 2013. View Article : Google Scholar : PubMed/NCBI
5	Feng S, Cong S, Zhang X, Bao X, Wang W, Li H, Wang Z, Wang G, Xu J, Du B, et al: MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 39:6669–6678. 2011. View Article : Google Scholar : PubMed/NCBI
6	Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, Olaru AV, Yang J, David S, Hamilton JP, et al: MicroRNA-192 and −215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 30:1577–1585. 2011. View Article : Google Scholar : PubMed/NCBI
7	Jin Y, Lu J, Wen J, Shen Y and Wen X: Regulation of growth of human bladder cancer by miR-192. Tumour Biol. 36:3791–3797. 2015. View Article : Google Scholar : PubMed/NCBI
8	Li J, Tan S, Kooger R, Zhang C and Zhang Y: MicroRNAs as novel biological targets for detection and regulation. Chem Soc Rev. 43:506–517. 2014. View Article : Google Scholar : PubMed/NCBI
9	Li J, Zhang W, Zhou M, Kooger R and Zhang Y: Small molecules modulating biogenesis or processing of microRNAs with therapeutic potentials. Curr Med Chem. 20:3604–3612. 2013. View Article : Google Scholar : PubMed/NCBI
10	Shan G, Li Y, Zhang J, Li W, Szulwach KE, Duan R, Faghihi MA, Khalil AM, Lu L, Paroo Z, et al: A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol. 26:933–940. 2008. View Article : Google Scholar : PubMed/NCBI
11	Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, et al: Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci USA. 108:4394–4399. 2011. View Article : Google Scholar : PubMed/NCBI
12	Watashi K, Yeung ML, Starost MF, Hosmane RS and Jeang KT: Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 285:24707–24716. 2010. View Article : Google Scholar : PubMed/NCBI
13	TargetScan, . http://www.targetscan.org/vert_71/
14	Liu JJ, Liu JY, Chen J, Wu YX, Yan P, Ji CD, Wang YX, Xiang DF, Zhang X, Zhang P, et al: Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients. Cancer Lett. 376:110–117. 2016. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Beekman JM, Reischl J, Henderson D, Bauer D, Ternes R, Peña C, Lathia C and Heubach JF: Recovery of microarray-quality RNA from frozen EDTA blood samples. J Pharmacol Toxicol Methods. 59:44–49. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kajiho H, Kajiho Y, Frittoli E, Confalonieri S, Bertalot G, Viale G, Di Fiore PP, Oldani A, Garre M, Beznoussenko GV, et al: RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs. EMBO Rep. 17:1061–1080. 2016. View Article : Google Scholar : PubMed/NCBI
18	Broughton T, Sington J and Beales IL: Statin use is associated with a reduced incidence of colorectal adenomatous polyps. Int J Colorectal Dis. 28:469–476. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wang H, Lu HM, Yang WH, Luo C, Lu SH, Zhou Y and Lin YZ: The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 24:215–218. 2012.(In Chinese). PubMed/NCBI
20	Rodriguez JA, Huerta-Yepez S, Law IK, Baay-Guzman GJ, Tirado-Rodriguez B, Hoffman JM, Iliopoulos D, Hommes DW, Verspaget HW, Chang L, et al: Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling. Cell Mol Gastroenterol Hepatol. 1:610–630. 2015. View Article : Google Scholar : PubMed/NCBI
21	Uwafuji S, Goi T, Naruse T, Kurebayashi H, Nakazawa T, Hirono Y and Yamaguchi A: Protein-bound polysaccharide K reduced the invasive ability of colon cancer cell lines. Anticancer Res. 33:4841–4845. 2013.PubMed/NCBI
22	Bao H, Zhang Q, Zhu Z, Xu H, Ding F, Wang M, Du S, Du Y and Yan Z: BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling. Sci Rep. 7:91532017. View Article : Google Scholar : PubMed/NCBI
23	Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA and Yousef GM: miR-192, miR-194 and miR-215: A convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI
24	Li L and Zhuang Z: Anticancer effects of statins and application in prevention and treatment of esophageal cancer. Chin J Gastroenterol. 18:493–496. 2013.(In Chinese).
25	Yu X, Pan Y, Ma H and Li W: Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells. Oncol Res. 20:351–357. 2013. View Article : Google Scholar : PubMed/NCBI
26	Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK and Rennert G: Statins and the risk of colorectal cancer. N Engl J Med. 352:2184–2192. 2005. View Article : Google Scholar : PubMed/NCBI